Patent 9446134 was granted and assigned to Aegis Therapeutics on September, 2016 by the United States Patent and Trademark Office.
The present invention relates to alkylglycoside-containing compositions and methods for increasing the stability, reducing the aggregation and immunogenicity, increasing the biological activity, and reducing or preventing fibrillar formation of a peptide, polypeptide, or variant thereof, for example octreotide or variant thereof.